Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-05-23
2006-05-23
Solola, Taofiq (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S504000
Reexamination Certificate
active
07049336
ABSTRACT:
Pharmaceutical compositions for treatment of primary hemostasis deficiency and methods of treatment of primary hemostasis deficiency are disclosed. Also, methods for diagnosing neuronal diseases and for suppressing the immune system are disclosed. Isoforms responsible for maintaining primary hemostasis, T-cell mediated immune responses, neuron specific TPH, and a neuronal tryptophan hydroxylase are disclosed.
REFERENCES:
patent: 3686414 (1972-08-01), Koe
patent: 4994475 (1991-02-01), Gittos
patent: 2004/0097576 (2004-05-01), Walther et al.
patent: 2105192 (1983-03-01), None
Raitano et al., 2004, CAS:140:230615.
Bader Michael
Walther Diego
Max-Delbruck-Centrum fur Molekularc Medizin
Saliwanchik Lloyd & Saliwanchik
Shiao Robert
Solola Taofiq
LandOfFree
Method for diagnosing neuronal diseases and for treating... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for diagnosing neuronal diseases and for treating..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for diagnosing neuronal diseases and for treating... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3539777